Assessment of the skin and ocular acceptance of Dexeclear Blemish Foaming Gel, through instrumental analysis, clinical efficacy and self-perceived efficacy by the subjects under normal conditions of use

Objective

Evaluate the acceptability of a Dexeclear Blemish Foaming Gel, confirming the absence of comedogenic / acnegenic potential, adverse events and cutaneous and ocular discomfort sensations, when applied under recommended conditions of use, under the supervision of a dermatologist and an ophthalmologist,

Population

33 adult subjects, mean age: 29 years old, phototype I to V . With acne prone skin, presenting showing facial acne spots, lack of homogeneity/ uniformity in skin tone, enlarged pores, and oily skin on the face.

Design (application)

Once or twice daily to the face for 28 days

Evaluation Criteria

Tolerance: dermatological and ophthalmological assessments
Efficacy: dermatological assessments (assessment of acne severity (IGA), acne lesions counting, PIH, pore opening, texture and homogeneity skin tone
Efficacy: evaluation through self-Assessment questionnaires
Skin oil assessments: Sebumeter®

Results

Very good tolerance

- statistically significant decrease of Sebum rate: -91%, immediately after application and statistically significant decrease of sebum rate: - 32% after 4 weeks of use

Conclusion

Very good tolerance

A significant decrease of 91% in sebum rate from the 1^st application

Acne

Efficacy and tolerability of KERACNYL serum in mild to moderate adult female acne

DUCRAY

Acne
Pediatrics

Tolerance and efficacy of KERACNYL Foaming Gel

DUCRAY

Tolerance and efficacy of KERACNYL Foaming Gel in combination with topical and oral acne treatments, under dermatological control

Acne
Pediatrics

Tolerance and efficacy of KERACNYL UV+ anti-blemish fluid

DUCRAY

Tolerance and efficacy of KERACNYL UV+ anti-blemish fluid in subjects with mild to moderate acne, under dermatological and ophthalmological control

Summary of clinical results